Product
Vyondys 53
1 clinical trial
1 indication
Indication
Duchenne muscular dystrophyClinical trial
A 48-Week, Open Label, Study to Evaluate the Efficacy and Safety of AMONDYS 45, EXONDYS 51, VYONDYS 53 in Subjects With DuchenneMuscular Dystrophy Carrying Eligible DMD Duplications.Status: Completed, Estimated PCD: 2021-09-01